Christopher Bunka
Chief Executive Officer at Lexaria Bioscience Corp.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Lexaria Bioscience Corp., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | Lexaria Bioscience Corp. | Gift | −100,000 | — | — |
| Jul 30, 2025 | Lexaria Bioscience Corp. | Open-market purchase | +11,900 | $0.91 | $10,829 |
| Jul 29, 2025 | Lexaria Bioscience Corp. | Open-market purchase | +15,600 | $0.92 | $14,352 |
| Jan 7, 2025 | Lexaria Bioscience Corp. | Grant or award | +100,000 | — | — |
Questions about Christopher Bunka
What boards is Christopher Bunka on?
Christopher Bunka sits on the board of Lexaria Bioscience Corp.
What company is Christopher Bunka the CEO of?
Christopher Bunka is Chief Executive Officer of Lexaria Bioscience Corp.
How long has Christopher Bunka served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.